Control of colorectal metastasis formation by K-Ras
- PMID: 16098678
- DOI: 10.1016/j.bbcan.2005.07.001
Control of colorectal metastasis formation by K-Ras
Abstract
Mutational activation of the K-Ras proto-oncogene is frequently observed during the very early stages of colorectal cancer (CRC) development. The mutant alleles are preserved during the progression from pre-malignant lesions to invasive carcinomas and distant metastases. Activated K-Ras may therefore not only promote tumor initiation, but also tumor progression and metastasis formation. Metastasis formation is a very complex and inefficient process: Tumor cells have to disseminate from the primary tumor, invade the local stroma to gain access to the vasculature (intravasation), survive in the hostile environment of the circulation and the distant microvascular beds, gain access to the distant parenchyma (extravasation) and survive and grow out in this new environment. In this review, we discuss the potential influence of mutant K-Ras on each of these phases. Furthermore, we have evaluated the clinical evidence that suggests a role for K-Ras in the formation of colorectal metastases.
Similar articles
-
K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells.Am Surg. 2001 Aug;67(8):802-5. Am Surg. 2001. PMID: 11510588
-
Role of oncogenic K-Ras in cancer stem cell activation by aberrant Wnt/β-catenin signaling.J Natl Cancer Inst. 2014 Feb;106(2):djt373. doi: 10.1093/jnci/djt373. J Natl Cancer Inst. 2014. PMID: 24491301
-
Evaluation of K-RAS gene in colorectal cancer.Folia Histochem Cytobiol. 2003;41(2):97-100. Folia Histochem Cytobiol. 2003. PMID: 12722796
-
No back seat for a progression event-K-RAS as a therapeutic target in CRC.Genes Dev. 2017 Feb 15;31(4):333-335. doi: 10.1101/gad.297630.117. Epub 2017 Mar 17. Genes Dev. 2017. PMID: 28314765 Free PMC article. Review.
-
[The RAS paradox of the EGFR-targeted therapy in colorectal cancer].Magy Onkol. 2008 Jun;52(2):185-91. doi: 10.1556/MOnkol.52.2008.2.7. Magy Onkol. 2008. PMID: 18640895 Review. Hungarian.
Cited by
-
Oncolytic virotherapy: molecular targets in tumor-selective replication and carrier cell-mediated delivery of oncolytic viruses.Biochim Biophys Acta. 2008 Apr;1785(2):217-31. doi: 10.1016/j.bbcan.2008.02.001. Epub 2008 Feb 15. Biochim Biophys Acta. 2008. PMID: 18328829 Free PMC article. Review.
-
Mast Cells, microRNAs and Others: The Role of Translational Research on Colorectal Cancer in the Forthcoming Era of Precision Medicine.J Clin Med. 2020 Sep 3;9(9):2852. doi: 10.3390/jcm9092852. J Clin Med. 2020. PMID: 32899322 Free PMC article. Review.
-
miR-450b-5p induced by oncogenic KRAS is required for colorectal cancer progression.Oncotarget. 2016 Sep 20;7(38):61312-61324. doi: 10.18632/oncotarget.11016. Oncotarget. 2016. PMID: 27494869 Free PMC article.
-
The pro-apoptotic K-Ras 4A proto-oncoprotein does not affect tumorigenesis in the ApcMin/+ mouse small intestine.BMC Gastroenterol. 2008 Jun 13;8:24. doi: 10.1186/1471-230X-8-24. BMC Gastroenterol. 2008. PMID: 18554389 Free PMC article.
-
Gab2 facilitates epithelial-to-mesenchymal transition via the MEK/ERK/MMP signaling in colorectal cancer.J Exp Clin Cancer Res. 2016 Jan 12;35:5. doi: 10.1186/s13046-015-0280-0. J Exp Clin Cancer Res. 2016. PMID: 26754532 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous